[1]. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation. 2006;113(20):2454-61.
[2]. Augustine DX, Howard L. Left Ventricular Hypertrophy in Athletes: Differentiating Physiology From Pathology. Curr Treat Options Cardiovasc Med. 2018;20(12):96.
[3]. Souza TA, Chen X, Guo Y, Sava P, Zhang J, Hill JJ, et al. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. Mol Endocrinol. 2008;22(12):2689-702. [4]. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A. 2001;98(16):9306-11.
[5]. Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE, et al. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell Metab. 2015;22(1):164-74.
[6]. Oh SP, Yeo CY, Lee Y, Schrewe H, Whitman M, Li E. Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev. 2002;16(21):274954.
[7]. Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014;344(6184):649-52.
[8]. Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013;153(4):828-39.
[9]. Wu HH, Ivkovic S, Murray RC, Jaramillo S, Lyons KM, Johnson JE, et al. Autoregulation of neurogenesis by GDF11. Neuron. 2003;37(2):197-207.
[10]. Rochette L, Zeller M, Cottin Y, Vergely C. Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration. Pharmacol Ther. 2015;156:26-33.
[11]. Wilkes JJ, Lloyd DJ, Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes. 2009;58(5):1133-43.
[12]. Keicho N, Matsushita I, Tanaka T, Shimbo T, Hang NT, Sakurada S, et al. Circulating levels of adiponectin, leptin, fetuin-A and retinol-binding protein in patients with tuberculosis: markers of metabolism and inflammation. PLoS One. 2012;7(6):e38703.
[13]. Lipina C, Kendall H, McPherron AC, Taylor PM, Hundal HS. Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice. FEBS Lett. 2010;584(11):2403-8.
[14]. Butcher JT, Ali MI, Ma MW, McCarthy CG, Islam BN, Fox LG, et al. Effect of myostatin deletion on cardiac and microvascular function. Physiol Rep. 2017;5(23).
[15]. Lach-Trifilieff E, Minetti GC, Sheppard K, Ibebunjo C, Feige JN, Hartmann S, et al. An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol. 2014;34(4):606-18. [16]. Bueno PG, Bassi D, Contrera DG, Carnielli HM, Silva RN, Nonaka KO, et al. Post-exercise changes in myostatin and actRIIB expression in obese insulin-resistant rats. Mol Cell Endocrinol. 2011;339(1-2):159-64.
[17]. Sheard PW, Anderson RD. Age-related loss of muscle fibres is highly variable amongst mouse skeletal muscles. Biogerontology. 2012;13(2):157-67.
[18]. Bashiri J, NourAzar A, Purrazi H. Effect of three months aerobic training on Wnt-signaling pathway in skeletal muscle of male rats. RJMS. 2017;24(7):7-16. (Persian).
[19]. Khadivi A, Marandi M, Haghjooy S, Hamid Rajabi, Khadivi Z, Behzadi M. Effect of 8 weeks resistance training on some signal factors affecting satellite cellularity in male Wistar rats. Journal of Isfahan Medical School. 2012;30(207):1500-11. (Persian).
[20]. De Domenico E, D'Arcangelo G, Faraoni I, Palmieri M, Tancredi V, Graziani G, et al. Modulation of GDF11 expression and synaptic plasticity by age and training. Oncotarget. 2017;8(35):57991-8002.
[21]. Elliott BT, Herbert P, Sculthorpe N, Grace FM, Stratton D, Hayes LD. Lifelong exercise, but not short-term highintensity interval training, increases GDF11, a marker of successful aging: a preliminary investigation. Physiol Rep. 2017;5(13).
[22]. Jamaiyar A, Wan W, Janota DM, Enrick MK, Chilian WM, Yin L. The versatility and paradox of GDF 11. Pharmacol Ther. 2017;175:28-34.
[23]. Fan X, Gaur U, Sun L, Yang D, Yang M. The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging. Mech Ageing Dev. 2017;164:108-12.
[24]. Negaresh R, Ranjbar R, Habibi A, Mokhtarzade M, Fokin A, Gharibvand MM. The effect of resistance training on quadriceps muscle volume and some growth factors in elderly and young men. Adv Gerontol. 2017;30(6):880-7. (Persian).
[25]. Paoli A, Pacelli QF, Neri M, Toniolo L, Cancellara P, Canato M, et al. Protein supplementation increases postexercise plasma myostatin concentration after 8 weeks of resistance training in young physically active subjects. J Med Food. 2015;18(1):137-43.
[26]. Hulmi JJ, Ahtiainen JP, Kaasalainen T, Pollanen E, Hakkinen K, Alen M, et al. Postexercise myostatin and activin IIb mRNA levels: effects of strength training. Med Sci Sports Exerc. 2007;39(2):289-97.
[27]. Poggioli T, Vujic A, Yang P, Macias-Trevino C, Uygur A, Loffredo FS, et al. Circulating Growth Differentiation Factor 11/8 Levels Decline With Age. Circ Res. 2016;118(1):29-37.
[28]. Rodgers BD, Eldridge JA. Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain. Endocrinology. 2015;156(11):3885-8.
[29]. Morvan F, Rondeau JM, Zou C, Minetti G, Scheufler C, Scharenberg M, et al. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy. Proc Natl Acad Sci U S A. 2017;114(47):12448-53.
[30]. Bondulich MK, Jolinon N, Osborne GF, Smith EJ, Rattray I, Neueder A, et al. Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice. Sci Rep. 2017;7(1):14275.
[31]. Chiu CS, Peekhaus N, Weber H, Adamski S, Murray EM, Zhang HZ, et al. Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents. J Gerontol A Biol Sci Med Sci. 2013;68(10):1181-92.